A First in Man, Phase I, Single-blind, Placebo-controlled Study Investigating the Local Tolerability, Safety and Pharmacokinetics in Three Doses of PXL01 and Placebo in 15 Healthy Volunteers
The main purpose of this study is to determine whether three different single doses of PXL01 are safe and well tolerated by healthy volunteers. The pharmacokinetic properties of PXL01 (same doses) will also be investigated.
100 项与 PharmaSurgics In Sweden AB 相关的临床结果
0 项与 PharmaSurgics In Sweden AB 相关的专利（医药）
100 项与 PharmaSurgics In Sweden AB 相关的药物交易
100 项与 PharmaSurgics In Sweden AB 相关的转化医学
